The overall tone indicates a moderate level of interest and engagement, demonstrated by mentions of the significance of CKD prevalence, dietary interventions, and calls for further exploration, such as 'Very informative #review' and references to the article's relevance. Words like 'very informative' and hashtags highlight recognition rather than active critique or extensive discussion, shaping a neutral, interest-focused summary.
AgreementNeither agree nor disagree
Most discussions acknowledge the credibility and importance of the publication, but few explicitly express strong support or disagreement.
InterestModerate interest
Participants show moderate curiosity, with some mentions of diet and CKD but limited deep exploration.
EngagementModerate engagement
Engagement is present through sharing basic information and general reactions, yet there is little detailed analysis or debate.
ImpactModerate impact
The conversations suggest awareness of the topic's relevance but do not reflect widespread influence or prompting significant changes in understanding.
Abstract in brief
Chronic kidney disease (CKD) is a growing global health issue, and recent research shows a link between CKD, the human microbiome, and its metabolites, with dysbiosis (microbial imbalance) observed in patients.
The relationship between CKD and microbiota is bidirectional: toxins from altered gut bacteria can worsen kidney function, while impaired kidneys also affect microbiome composition; some microbial metabolites can harm or help kidney health.
Modulating the gut microbiome through diet (like low-protein, high-fiber diets) and other strategies shows promise for improving CKD outcomes by increasing beneficial metabolites and reducing harmful toxins.]
Congrats to our PhD student Eman Wehedy @HBKU @SidraMedicine
Very informative #review
The Human #Microbiome in Chronic Kidney Disease: A Double-Edged Sword #CKD #OpenAccess https://t.co/Ag2PCuuhn1
This video explores the potential effects of Epigallocatechin-3-gallate (EGCG) from green tea in treating Alzheimer's disease and kidney conditions, summarizing preclinical studies and clinical perspectives on its…
This video explores the potential effects of Epigallocatechin-3-gallate (EGCG) in the pathogenesis of Alzheimer's disease, reviewing preclinical studies and clinical perspectives on its therapeutic efficacy.
Explores the efficacy of Epigallocatechin-3-Gallate (EGCG) from green tea in treating Alzheimer's disease, reviewing preclinical studies and potential clinical applications, highlighting its neuroprotective effects and…
Chronic kidney disease affects 13% of the population worldwide. Studies show that high-fiber diet improves kidney function by lowering the harmful uremic metabolite levels. What are the symptoms of chronic kidney disease?
https://t.co/YNuAdaoDng.
@HPEX353_1 #HPEX353_1 #HRD
Congrats to our PhD student Eman Wehedy @HBKU @SidraMedicine
Very informative #review
The Human #Microbiome in Chronic Kidney Disease: A Double-Edged Sword #CKD #OpenAccess https://t.co/Ag2PCuuhn1
“The Human Microbiome in Chronic Kidney Disease: A Double- Edged Sword.” Frontiers in Medicine, vol. 8, 17 Jan. 2022, https://doi.org/10.3389/fmed.2021.790783.